Aflac Incorporated (NYSE:AFL) Shares Sold by Schechter Investment Advisors LLC

Schechter Investment Advisors LLC cut its position in Aflac Incorporated (NYSE:AFL) by 12.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,185 shares of the financial services provider’s stock after selling 581 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Aflac were worth $433,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new position in Aflac during the 4th quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac during the third quarter worth about $34,000. BankPlus Trust Department purchased a new position in shares of Aflac in the fourth quarter valued at approximately $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the third quarter valued at approximately $38,000. Finally, Covestor Ltd grew its holdings in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Barclays reduced their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Evercore ISI reduced their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Keefe, Bruyette & Woods reduced their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Finally, BMO Capital Markets started coverage on Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $103.36.

Insider Transactions at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares in the company, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.90% of the company’s stock.

Aflac Stock Up 0.6 %

AFL stock opened at $108.20 on Thursday. The stock has a market cap of $59.14 billion, a P/E ratio of 11.27, a PEG ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50. The company’s 50 day moving average is $104.89 and its two-hundred day moving average is $107.67.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.